IL6 and metabolic syndrome: Elevated neutrophil levels in individuals with MetS serve as markers of increased systemic inflammation, driven in part by pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α).